| 1.5 |
4.6 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.9 |
13.1 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.9 |
0.9 |
GO:0061324 |
canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) |
| 0.8 |
2.5 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 0.8 |
6.5 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.8 |
2.4 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.8 |
3.1 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.7 |
0.7 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.7 |
2.1 |
GO:1904956 |
regulation of midbrain dopaminergic neuron differentiation(GO:1904956) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 0.7 |
2.1 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.7 |
2.1 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.7 |
1.3 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.6 |
1.9 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 0.6 |
2.5 |
GO:1903977 |
positive regulation of glial cell migration(GO:1903977) |
| 0.6 |
2.4 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.5 |
4.2 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.5 |
3.1 |
GO:1903753 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) negative regulation of p38MAPK cascade(GO:1903753) |
| 0.5 |
1.5 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.5 |
2.0 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.5 |
4.4 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.5 |
1.5 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 0.5 |
1.9 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.5 |
1.4 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.5 |
2.7 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.5 |
1.4 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.4 |
1.3 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.4 |
2.2 |
GO:0072368 |
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.4 |
1.7 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.4 |
2.0 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 0.4 |
1.2 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.4 |
3.5 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.4 |
3.8 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.4 |
1.8 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.4 |
0.7 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.4 |
1.1 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.4 |
1.1 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.4 |
2.1 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.3 |
1.4 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.3 |
1.0 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.3 |
1.7 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.3 |
0.3 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.3 |
0.3 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.3 |
1.3 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.3 |
1.5 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.3 |
1.2 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.3 |
1.5 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.3 |
2.0 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.3 |
1.7 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.3 |
1.1 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.3 |
1.9 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.3 |
1.1 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.3 |
2.5 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.3 |
2.2 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.3 |
0.8 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.3 |
1.6 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.3 |
0.5 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.3 |
2.6 |
GO:0098739 |
import across plasma membrane(GO:0098739) |
| 0.3 |
0.8 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.2 |
0.7 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.2 |
1.0 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 |
1.5 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.2 |
1.0 |
GO:2000383 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.2 |
1.2 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.2 |
1.8 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.2 |
0.9 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.2 |
1.1 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.2 |
1.8 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.2 |
0.7 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.2 |
0.7 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.2 |
0.2 |
GO:0048382 |
mesendoderm development(GO:0048382) |
| 0.2 |
1.1 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.2 |
1.5 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
| 0.2 |
0.6 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.2 |
0.6 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.2 |
0.6 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.2 |
2.2 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.2 |
1.2 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.2 |
0.8 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.2 |
0.6 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.2 |
0.8 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 |
0.6 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.2 |
1.5 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.2 |
1.3 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.2 |
0.4 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.2 |
1.1 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.2 |
0.4 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.2 |
0.5 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 0.2 |
0.5 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.2 |
0.9 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
0.9 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.2 |
0.9 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 |
4.1 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.2 |
2.2 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.2 |
0.5 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.2 |
0.5 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.2 |
0.7 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
3.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
0.2 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.2 |
0.7 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.2 |
0.3 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.2 |
0.6 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.2 |
0.5 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.2 |
1.3 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.2 |
1.2 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 |
1.4 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.2 |
0.6 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.2 |
0.9 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 |
0.4 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.4 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 |
1.2 |
GO:2000809 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.1 |
0.6 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.4 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.1 |
0.7 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 |
0.1 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 0.1 |
0.6 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.1 |
1.1 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.4 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.1 |
1.1 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.1 |
1.8 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
1.2 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
0.7 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.1 |
1.5 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.1 |
0.5 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.1 |
0.9 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.3 |
GO:0034698 |
response to gonadotropin(GO:0034698) cellular response to gonadotropin stimulus(GO:0071371) |
| 0.1 |
0.4 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 |
0.9 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.4 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 |
1.1 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
1.1 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.8 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
0.4 |
GO:0072578 |
neurotransmitter-gated ion channel clustering(GO:0072578) |
| 0.1 |
0.3 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.5 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.1 |
1.7 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.9 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 |
0.9 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.1 |
1.4 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.1 |
1.0 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.3 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
0.4 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.1 |
0.3 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.1 |
0.4 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
1.0 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.2 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.1 |
0.3 |
GO:0071649 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.1 |
0.3 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
0.7 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.1 |
0.6 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
0.4 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.1 |
0.3 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 |
0.6 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 |
1.2 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.1 |
0.3 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 |
0.6 |
GO:0032346 |
positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 0.1 |
0.8 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.1 |
0.3 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.1 |
0.4 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.1 |
0.3 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.1 |
0.8 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.5 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.9 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 |
0.3 |
GO:2000054 |
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.1 |
0.9 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
0.6 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.4 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.1 |
0.3 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.3 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.2 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.1 |
0.7 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 |
0.4 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
0.5 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
2.3 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 |
0.6 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
0.4 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 |
0.4 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 |
0.1 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.1 |
0.1 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.1 |
0.1 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.1 |
0.6 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.3 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.1 |
0.2 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.1 |
0.7 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.2 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.1 |
4.3 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
1.5 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.1 |
0.5 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.2 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.1 |
0.3 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 |
0.5 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
0.2 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.1 |
0.3 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.1 |
0.2 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.1 |
0.7 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
0.2 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.1 |
0.3 |
GO:0090273 |
regulation of somatostatin secretion(GO:0090273) |
| 0.1 |
1.2 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 |
0.5 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.2 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
0.3 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.1 |
0.7 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 |
0.4 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.1 |
0.5 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
0.9 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 |
0.5 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.1 |
0.4 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
1.1 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
1.0 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
0.6 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
0.4 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.1 |
0.2 |
GO:0097278 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) complement-dependent cytotoxicity(GO:0097278) |
| 0.1 |
0.4 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.1 |
0.3 |
GO:0021882 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
| 0.1 |
0.2 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.2 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.5 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.1 |
0.4 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.1 |
0.6 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
1.1 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.1 |
0.4 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.1 |
0.1 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.1 |
0.6 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.3 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.1 |
0.3 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.1 |
0.3 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.1 |
1.1 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.6 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
0.5 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
0.4 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
0.3 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
1.0 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 |
0.2 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.1 |
0.8 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.1 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.9 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
0.4 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.1 |
0.2 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.1 |
0.4 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 |
1.3 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.3 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 |
0.6 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
5.0 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.1 |
0.4 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
0.3 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.1 |
0.3 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 |
0.2 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.3 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
1.3 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.2 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.1 |
0.7 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
0.2 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
0.3 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
0.1 |
GO:0021898 |
commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.1 |
0.7 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
0.7 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.1 |
0.4 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.0 |
0.3 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.0 |
0.1 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.0 |
0.0 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.0 |
0.3 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.0 |
1.2 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.5 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.0 |
1.2 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.0 |
0.2 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.9 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.4 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.0 |
0.1 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.0 |
0.6 |
GO:0051043 |
regulation of membrane protein ectodomain proteolysis(GO:0051043) positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.8 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 |
0.4 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.2 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.0 |
0.1 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.0 |
0.1 |
GO:0045359 |
positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.0 |
0.6 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.1 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.0 |
0.2 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.3 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.1 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.0 |
0.1 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.0 |
0.3 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.3 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.0 |
1.1 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.7 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.0 |
0.6 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.1 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.8 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.8 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.0 |
0.0 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.0 |
0.0 |
GO:0060423 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.0 |
0.2 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.1 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.0 |
0.2 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.6 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.0 |
0.2 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.2 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.0 |
0.2 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 0.0 |
0.7 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
0.6 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.2 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.2 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.0 |
0.5 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.0 |
0.8 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.1 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.0 |
0.2 |
GO:0071372 |
response to follicle-stimulating hormone(GO:0032354) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.0 |
0.9 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.0 |
0.3 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.0 |
0.3 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.3 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.0 |
0.4 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.0 |
0.1 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.0 |
0.4 |
GO:0009651 |
response to salt stress(GO:0009651) |
| 0.0 |
0.2 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.0 |
0.9 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.0 |
0.2 |
GO:0046519 |
sphingoid metabolic process(GO:0046519) |
| 0.0 |
0.9 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.0 |
0.3 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 |
0.9 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.7 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.3 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.0 |
0.3 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.0 |
0.9 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.2 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.0 |
0.4 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.6 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.3 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.3 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 |
0.3 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.0 |
0.3 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.0 |
0.2 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.0 |
0.1 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.0 |
0.5 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.2 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.0 |
0.2 |
GO:0033273 |
response to vitamin(GO:0033273) |
| 0.0 |
0.5 |
GO:0006152 |
purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
| 0.0 |
0.5 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
0.4 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.1 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.0 |
0.2 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.0 |
0.2 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 |
1.5 |
GO:0034394 |
protein localization to cell surface(GO:0034394) |
| 0.0 |
0.4 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.0 |
0.2 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.1 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.0 |
0.4 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.0 |
0.2 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 |
1.5 |
GO:0050868 |
negative regulation of T cell activation(GO:0050868) |
| 0.0 |
0.2 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.3 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.2 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.0 |
0.1 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
| 0.0 |
0.5 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
0.3 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 0.0 |
1.2 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.0 |
0.6 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.0 |
0.8 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.3 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.3 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 |
0.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.1 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
0.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.1 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) Harderian gland development(GO:0070384) |
| 0.0 |
0.3 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.1 |
GO:0046051 |
GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
| 0.0 |
0.1 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.1 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 |
0.4 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.5 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.1 |
GO:0002716 |
negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.0 |
0.6 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.0 |
0.2 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.0 |
0.0 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.0 |
0.1 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 |
2.2 |
GO:0098656 |
anion transmembrane transport(GO:0098656) |
| 0.0 |
0.3 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.2 |
GO:0002591 |
positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
| 0.0 |
0.1 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 |
1.5 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.0 |
0.2 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.6 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.7 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 |
0.2 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.0 |
0.3 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.0 |
0.3 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.0 |
0.1 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.0 |
0.3 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.0 |
0.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.6 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.4 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.0 |
0.1 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.0 |
0.5 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 |
0.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.7 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
| 0.0 |
0.6 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) |
| 0.0 |
0.4 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.0 |
0.1 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.0 |
0.1 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.3 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.3 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.2 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
2.5 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.0 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
0.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.4 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.2 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.0 |
0.5 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
0.1 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.0 |
0.0 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 |
0.4 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.2 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.0 |
0.0 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.0 |
0.1 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 |
0.3 |
GO:0046326 |
positive regulation of glucose import(GO:0046326) |
| 0.0 |
0.1 |
GO:0060579 |
ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.0 |
0.2 |
GO:1902652 |
cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
| 0.0 |
0.1 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.3 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
0.1 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
0.1 |
GO:0032964 |
collagen biosynthetic process(GO:0032964) |
| 0.0 |
1.4 |
GO:0071805 |
potassium ion transmembrane transport(GO:0071805) |
| 0.0 |
0.1 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.4 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.0 |
0.3 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.1 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.0 |
0.2 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.0 |
0.4 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.0 |
0.2 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.0 |
GO:0090306 |
spindle assembly involved in meiosis(GO:0090306) |
| 0.0 |
0.3 |
GO:0048041 |
cell-substrate junction assembly(GO:0007044) cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
| 0.0 |
0.2 |
GO:0007569 |
cell aging(GO:0007569) |
| 0.0 |
0.1 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.0 |
0.1 |
GO:0006821 |
chloride transport(GO:0006821) |
| 0.0 |
0.2 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 |
0.1 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.0 |
0.2 |
GO:0097035 |
regulation of membrane lipid distribution(GO:0097035) |
| 0.0 |
0.1 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.1 |
GO:0030431 |
sleep(GO:0030431) |
| 0.0 |
0.1 |
GO:0060442 |
branching involved in prostate gland morphogenesis(GO:0060442) |
